menu search

Sana biotechnology announces increased focus on hypoimmune-related pipeline with the potential to deliver clinical proof of concept data from four programs in 2023 and 2024 with a 2024 operating burn

Increasing focus on ex vivo cell therapy platform based on extensive preclinical and early translational clinical data suggesting ability of hypoimmun...

October 10, 2023, 8:15 pm

Why shares of 89bio plummeted on tuesday

89bio is a clinical-stage biotech company. It focuses on treatments for liver and cardiometabolic disea...

October 10, 2023, 4:13 pm

Inovio shares rise after positive fda feedback on rrp treatment candidate

Biotechnology company Inovio saw its shares jump after the US FDA communicated that data from Inovio completed Phase 1/2 trial of INO-3107 for treatin...

October 10, 2023, 2:47 pm

Why shares of ventyx biosciences are dropping tuesday

Ventyx is a clinical-stage biotech that focuses on autoimmune disorders. The company's lead therapy can...

October 10, 2023, 12:55 pm

Tango therapeutics (tngx) rises 20% in a month: here's why

The upside in Tango's (TNGX) shares can be attributed to the company's progress with its pipeline candidates. A recent acquisition offer for a ...

October 10, 2023, 12:47 pm

Cancer biotechs pique buyout interest: recent deals in focus

The M&A trend of 2023 shows that there is an increasing interest in biotech companies making innovative...

October 10, 2023, 12:47 pm

Cybrexa therapeutics to debut preclinical data demonstrating cbx-15 is safe and highly efficacious in 13762 triple negative breast cancer model at 35th aacr-nci-eortc symposium

Preclinical Data Demonstrate CBX-15’s Anti-Tumor Efficacy in Animal Models and Ability to Enhance Immunogenicity and Induce Immune Memory through pH...

October 10, 2023, 12:05 pm

Windtree to participate in the lytham partners fall 2023 investor conference on october 17th

WARRINGTON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnolog...

October 10, 2023, 11:30 am

biotech stock sinks after disappointing trial

Akero Therapeutics Inc (NASDAQ:AKRO) is plummeting to 52-week lows, after its treatment for severe fatty liver disease, efruxifermin, missed its main...

October 10, 2023, 11:18 am

Fortress biotech announces reverse stock split

MIAMI, Oct. 09, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or the “Company”), an innovative biopharmaceutical...

October 9, 2023, 4:50 pm

Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023

SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu...

October 9, 2023, 4:10 pm

Analysts target biotech name on buyout buzz

Mirati Therapeutics Inc (NASDAQ:MRTX) stock is dropping today, after news that Bristol-Myers Squibb (BMY) will acquire the company for up to $5.8 bill...

October 9, 2023, 3:03 pm

Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023

SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immun...

October 9, 2023, 12:10 pm

Why shares of tango therapeutics are dropping monday

Tango Therapeutics is a clinical-stage biotech. The company has five programs in its pipeline that are focused on fighting various cancers....

October 9, 2023, 11:53 am

Bear of the day: illumina (ilmn)

Illumina ( ILMN ), the maker of million-dollar genome sequencing machines that revolutionized the fields of genetics and biotechnology, has fallen har...

October 9, 2023, 7:31 am

Novartis leads funding round for uk alzheimer's specialist

UK-based biotech firm AstronauTx has secured £48 million ($61 million) in a significant Series A fundi...

October 9, 2023, 2:16 am

3 pharma stocks to dump before the damage is done

Pharma stocks and the biotech sector can offer explosive gains. It also offers incredibly crushing defe...

October 8, 2023, 8:00 am

2 growth stocks that could rocket higher before the end of 2023

Upcoming announcements from the U.S. Food and Drug Administration could cause several biotech stocks to...

October 8, 2023, 6:29 am

3 biotech stocks ready to break out in 2024

While the S&P 500 remains up on the year, the biotech sector is down. Even though the broader market is...

October 7, 2023, 9:00 am

Why shares of cassava sciences soared this week

A rash of insider buying helped buoy the clinical-stage biotech's stock. Cassava said it had completed the enrollment of a phase 3 trial for an Alzhei...

October 6, 2023, 3:13 pm


Search within

Pages Search Results: